Related Experiment Videos
Down-rating lifetime suicide risk in major depression
G W Blair-West1, G W Mellsop, M L Eyeson-Annan
1Community Psychiatry Service, Toowong Private Hospital, Brisbane, Australia.
Acta Psychiatrica Scandinavica
|March 1, 1997
Summary
The lifetime suicide risk for major depressive disorder (MDD) is likely 3.5%, not the previously accepted 15%. This study revises the understanding of suicide risk in depression, highlighting methodological factors in prior research.
Area of Science:
- Psychiatry
- Epidemiology
- Mental Health Research
Background:
- The established medical consensus for 25 years indicated a 15% lifetime suicide risk for individuals with major depressive disorder (MDD).
- Previous studies may have overestimated suicide risk due to methodologies focusing on specific, high-risk patient groups.
Purpose of the Study:
- To re-evaluate and provide a more accurate estimation of the lifetime suicide risk in patients diagnosed with major depressive disorder (MDD).
- To identify factors contributing to the historical overestimation of suicide risk in MDD research.
Main Methods:
- Utilized conservative age-specific calculations to determine lifetime suicide risk.
- Analyzed the impact of study population selection (hospital-based vs. out-patient) on reported suicide risk.
- Considered the influence of evolving diagnostic classification systems on risk assessment.
Main Results:
- Conservative age-specific calculations suggest a lifetime suicide risk of 3.5% for MDD.
- Selection bias in prior research, particularly the use of hospital-based populations, significantly inflated perceived suicide risk.
- MDD is not a homogenous category regarding suicide risk; hospitalized patients show a substantially higher risk.
Conclusions:
- The lifetime suicide risk for major depressive disorder (MDD) is estimated to be significantly lower than previously accepted.
- Methodological factors, including patient selection and diagnostic criteria, are crucial for accurate suicide risk assessment in MDD.
- Future research should account for diagnostic heterogeneity and patient population characteristics to refine suicide risk estimates.